2021
DOI: 10.1002/rcr2.785
|View full text |Cite
|
Sign up to set email alerts
|

Successful endobronchial occlusion in empyema with broncho‐pleural fistula secondary to COVID‐19 pneumonia: a case report and literature review

Abstract: A few cases of empyema secondary to coronavirus disease 2019 (COVID‐19) pneumonia have been reported. Here, we report our experience of a successful endobronchial occlusion using endobronchial Watanabe spigots (EWSs) for empyema with broncho‐pleural fistula secondary to COVID‐19 pneumonia. A 62‐year‐old man was diagnosed with COVID‐19 and progressed to empyema with broncho‐pleural fistula. Computed tomography (CT) imaging showed cyst formation and the right B 5 b was presumed to be a bra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…In our case, the empyema cavity was closed approximately 50 days after OWT and the lung expanded well, suggesting that the procedure was somewhat effective. There are few reports of pleural empyema with BPFs after COVID-19, which are often treated invasively 7) , and while pleural empyema with BPF is often secondary to lung resection and pleural empyema secondary to COVID-19, as seen in this case, generally does not require lung resection. This finding suggests that NPWT is a good option for the treatment of pleural empyema secondary to COVID-19.…”
Section: Discussionmentioning
confidence: 75%
“…In our case, the empyema cavity was closed approximately 50 days after OWT and the lung expanded well, suggesting that the procedure was somewhat effective. There are few reports of pleural empyema with BPFs after COVID-19, which are often treated invasively 7) , and while pleural empyema with BPF is often secondary to lung resection and pleural empyema secondary to COVID-19, as seen in this case, generally does not require lung resection. This finding suggests that NPWT is a good option for the treatment of pleural empyema secondary to COVID-19.…”
Section: Discussionmentioning
confidence: 75%
“…Five cases of empyema secondary to COVID‐19 have been reported to date, including two cases of pleural fistula. All five patients were treated with surgical intervention, such as decortication, and four of these cases resulted in a good clinical course [10] . Our case is the first presentation of bilateral infected hydropneumothorax in the patient with COVID 19 pneumonia treated without surgical intervention.…”
Section: Discussionmentioning
confidence: 99%
“…Both heart failure and pulmonary embolism in addition to respiratory co-infections are well-recognized aetiologies of pleural effusions [8] . A few cases of a complicated parapneumonic effusion (empyema) secondary to coronavirus disease 2019 (COVID-19) pneumonia have been reported [ 9 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%